EMD-43794
COVA2-15 fragment antigen binding in complex with SARS-CoV-2 6P-mut7 S protein
EMD-43794
Single-particle3.9 Å
Deposition: 23/02/2024Map released: 29/01/2025
Last modified: 28/05/2025
Sample Organism:
Severe acute respiratory syndrome coronavirus 2,
Homo sapiens
Sample: COVA2-15 fragment antigen binding in complex with SARS-CoV-2 6P-mut7 S protein
Fitted models: 9aru
Deposition Authors: Ozorowski G, Turner HL, Ward AB
Sample: COVA2-15 fragment antigen binding in complex with SARS-CoV-2 6P-mut7 S protein
Fitted models: 9aru
Deposition Authors: Ozorowski G, Turner HL, Ward AB
Plant-produced SARS-CoV-2 antibody engineered towards enhanced potency and in vivo efficacy.
de Taeye SW 
,
Faye L,
Morel B,
Schriek AI,
Umotoy JC,
Yuan M ,
Kuzmina NA,
Turner HL,
Zhu X,
Grunwald-Gruber C,
Poniman M,
Burger JA,
Caniels TG,
Fitchette AC,
Desgagnes R,
Stordeur V,
Mirande L,
Beauverger G,
de Bree G,
Ozorowski G,
Ward AB,
Wilson IA,
Bukreyev A,
Sanders RW,
Vezina LP,
Beaumont T,
van Gils MJ,
Gomord V
(2025) Plant Biotechnol J , 23 , 4 - 16
,
Faye L,
Morel B,
Schriek AI,
Umotoy JC,
Yuan M ,
Kuzmina NA,
Turner HL,
Zhu X,
Grunwald-Gruber C,
Poniman M,
Burger JA,
Caniels TG,
Fitchette AC,
Desgagnes R,
Stordeur V,
Mirande L,
Beauverger G,
de Bree G,
Ozorowski G,
Ward AB,
Wilson IA,
Bukreyev A,
Sanders RW,
Vezina LP,
Beaumont T,
van Gils MJ,
Gomord V
(2025) Plant Biotechnol J , 23 , 4 - 16
Grant Support: